select a format

Single User License
USD 2500 INR 161150
Site License
USD 5000 INR 322300
Corporate User License
USD 7500 INR 483450

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015

Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2630CTIDB
  • |
  • Pages: 75
  • |
  • April 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2015" provides data on the Tachycardia (Tachyarrhythmias) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tachycardia (Tachyarrhythmias). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tachycardia (Tachyarrhythmias). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Tachycardia (Tachyarrhythmias) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Tachycardia (Tachyarrhythmias) 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

St. Jude Medical, Inc. 32

Clinical Trial Overview of St. Jude Medical, Inc. 32

Ono Pharmaceutical Co., Ltd. 33

Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 33

Chemo Espana, S.A. 34

Clinical Trial Overview of Chemo Espana, S.A. 34

Gilead Sciences, Inc. 35

Clinical Trial Overview of Gilead Sciences, Inc. 35

Baxter International Inc. 36

Clinical Trial Overview of Baxter International Inc. 36

Aop Orphan Pharmaceuticals AG 37

Clinical Trial Overview of Aop Orphan Pharmaceuticals AG 37

Actavis plc 38

Clinical Trial Overview of Actavis plc 38

Gilead Sciences 39

Clinical Trial Overview of Gilead Sciences 39

Biotronik SE & Co. KG 40

Clinical Trial Overview of Biotronik SE & Co. KG 40

AstraZeneca PLC 41

Clinical Trial Overview of AstraZeneca PLC 41

Clinical Trial Overview of Top Institutes / Government 42

Vanderbilt University 42

Clinical Trial Overview of Vanderbilt University 42

National Heart, Lung, and Blood Institute 43

Clinical Trial Overview of National Heart, Lung, and Blood Institute 43

Meshalkin Research Institute of Pathology of Circulation 44

Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation 44

Deutsches Herzzentrum Munchen 45

Clinical Trial Overview of Deutsches Herzzentrum Munchen 45

Duke University 46

Clinical Trial Overview of Duke University 46

Hospital Clinic de Barcelona 47

Clinical Trial Overview of Hospital Clinic de Barcelona 47

Institut de Recherches Internationales Servier 48

Clinical Trial Overview of Institut de Recherches Internationales Servier 48

Mayo Clinic 49

Clinical Trial Overview of Mayo Clinic 49

New York Medical College 50

Clinical Trial Overview of New York Medical College 50

The Johns Hopkins University 51

Clinical Trial Overview of The Johns Hopkins University 51

Five Key Clinical Profiles 52

Appendix 73

Abbreviations 73

Definitions 73

Research Methodology 74

Secondary Research 74

About GlobalData 75

Contact Us 75

Disclaimer 75

Source 75

List of Figures

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Tachycardia (Tachyarrhythmias) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Tachycardia (Tachyarrhythmias) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Tachycardia (Tachyarrhythmias) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Tachycardia (Tachyarrhythmias) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Tachycardia (Tachyarrhythmias) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 74

List of Tables

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Tachycardia (Tachyarrhythmias) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Tachycardia (Tachyarrhythmias) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Tachycardia (Tachyarrhythmias) to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Tachycardia (Tachyarrhythmias) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Tachycardia (Tachyarrhythmias) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Tachycardia (Tachyarrhythmias) Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27

Tachycardia (Tachyarrhythmias) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2015* 32

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2015* 33

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 34

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 35

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 36

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aop Orphan Pharmaceuticals AG, 2015* 37

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 38

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2015* 39

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2015* 40

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 41

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 42

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 43

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2015* 44

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2015* 45

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 46

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 47

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2015* 48

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 49

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York Medical College, 2015* 50

Tachycardia (Tachyarrhythmias) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Tachycardia (Tachyarrhythmias) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Tachycardia (Tachyarrhythmias), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com